摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Cu(II)(N,N'-o-phenylenebis(3-ethoxysalicylaldimine)]*H2O | 1270936-55-4

中文名称
——
中文别名
——
英文名称
[Cu(II)(N,N'-o-phenylenebis(3-ethoxysalicylaldimine)]*H2O
英文别名
——
[Cu(II)(N,N'-o-phenylenebis(3-ethoxysalicylaldimine)]*H2O化学式
CAS
1270936-55-4
化学式
C24H22N2O4*Cu*H2O
mdl
——
分子量
484.011
InChiKey
JBMHBMPRLNKMNP-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.31
  • 重原子数:
    32.0
  • 可旋转键数:
    8.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    120.8
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    描述:
    calcium perchlorate tetrahydrate 、 [Cu(II)(N,N'-o-phenylenebis(3-ethoxysalicylaldimine)]*H2O甲醇丙酮 为溶剂, 以74%的产率得到[Cu(II)(N,N'-o-phenylenebis(3-ethoxysalicylaldimine)Ca(II)(ClO4)2(H2O)]
    参考文献:
    名称:
    N,N'-o-亚苯基双(3-乙氧基水杨醛亚胺)衍生的铜(II)-主族金属配合物的合成、晶体结构和超分子拓扑结构
    摘要:
    摘要 本研究报告了 11 种铜 (II)-主族金属离子配合物 [CuIILNaI(NO3)(H2O)]·2CH3CN (1)、[CuIIILNaI(N3)(CH3OH) 的合成、晶体结构和超分子拓扑结构。 )]·CH3OH (2), [CuIILNaI(ClO4)(CH3CN)]·0.5CH3CN (3), [CuIILNaI(BF4)(CH3OH)]·H2O (4), [{CuIILNaI(H2O)}2(CuIIL) ](BPh4)2 (5), [CuIILKI(ClO4)(CH3COCH3)] (6), [CuIILCaII(ClO4)2(H2O)] (7), [{CuIILCaII(NO3)(μ-NO3)(H2O) }(CuIIL)]·H2O·CH3COCH3 (8), [(CuIIL)2BaII(NO3)2]·CH3OH (9), [CuIILPbII(NO3)2]·CH3OH (10)
    DOI:
    10.1016/j.molstruc.2011.08.005
点击查看最新优质反应信息

文献信息

  • Two New Diphenoxo‐Bridged Discrete Dinuclear Cu <sup>II</sup> Gd <sup>III</sup> Compounds with Cyclic Diimino Moieties: Syntheses, Structures, and Magnetic Properties
    作者:Rajesh Koner、Gene‐Hsiang Lee、Yu Wang、Ho‐Hsiang Wei、Sasankasekhar Mohanta
    DOI:10.1002/ejic.200400858
    日期:2005.4
    Two Schiff base compartmental ligands, H 2 L 1 and H 2 L 2 , derived from the condensation of 3-ethoxysalicylaldehyde with 1,2-diaminocyclohexane and orthophenylenediamine, respectively, have been utilized to isolate two diphenoxo-bridged discrete dinuclear Cu I I Gd I I I complexes, [Cu I I (H 2 O)-L 1 Gd I I I (NO 3 ) 3 ] (3) and [Cu I I L 2 Gd I I I (NO 3 ) 3 ] (4). This is the first report on the
    两个席夫碱区室配体 H 2 L 1 和 H 2 L 2 分别源自 3-乙氧基水杨醛1,2-二氨基环己烷邻苯二胺的缩合,已被用于分离两个二苯氧桥连的离散双核 Cu II Gd III络合物,[Cu II (H 2 O)-L 1 Gd III (NO 3 ) 3 ] (3) 和 [Cu IIL 2 Gd III (NO 3 ) 3 ] (4)。这是关于由带环二胺的隔室 Schiff 碱配体衍生的 3d-4f 化合物的首次报告。化合物 3 和 4 分别在三斜 Pi 和正交 Pna2(1) 空间群中结晶,晶胞参数如下 - 3:a = 8.8713(2) A, b = 12.8399(3) A, c = 14.0067( 3) A, a = 80.6649(5)°, β = 77.4059(5)°, γ = 76.8879(5)°, Z = 2;4:a = 9.2210(1) A,b = 16
  • Self-assembled [2×1+1×2] heterotetranuclear CuII3MnII/CuII3CoII and [2×2+1×3] heptanuclear CuII7 compounds derived from N,N′-o-phenylenebis(3-ethoxysalicylaldimine): Structures and magnetic properties
    作者:Malabika Nayak、Susanta Hazra、Pascale Lemoine、Rajesh Koner、C. Robert Lucas、Sasankasekhar Mohanta
    DOI:10.1016/j.poly.2007.12.010
    日期:2008.3
    copper(II) compound [CuIIL1⊂(H2O)] (1) derived from the hexadentate Schiff base compartmental ligand N,N′-o-phenylenebis(3-ethoxysalicylaldimine) (H2L1) has been characterized from its IR spectrum as an inclusion product. Reaction of 1 with Cu(ClO4)2 · 6H2O leads to the formation of an interesting [2 × 2 + 1 × 3] heptanuclear copper(II) complex [CuIIL1CuII(H2O)3}2 CuIIL1}3](ClO4)4 · 2CH3COCH3 (2), in which
    摘要从六齿席夫碱隔室配体N,N'-邻苯撑双(3-乙氧基水杨醛亚胺)(H2L1)衍生得到单核(II)化合物[CuIIL1⊂(H2O)](1),其红外光谱为包容产品。1与Cu(ClO4)2·6 的反应导致形成有趣的[2×2 + 1×3]七核(II)络合物[CuIIL1CuII( )3} 2 CuIIL1} 3]( ) 4·2CH3COCH3(2),其中两个单氧桥联的双核[CuIIL1CuII( )3] 2+阳离子单元是自组装的,并通过三个单核[CuIIL1]络合物单元通过配位分子之间形成的氢键网共结晶。和苯氧/乙氧基氧。1与Co( )2·6 或Mn( )2·6 的相似反应产生[2×1 +1×2]异四核配合物[CuIIL1MII( )3} CuIIL1} 2]( )2 · ·CH3COCH3(M = Co(3),M = Mn(4
  • Exploration of heterometallic systems containing silver(I) in acyclic Schiff base ligands: Finite and infinite self-assemblies as a result of silver(I)–carbon bond and silver(I)⋯silver(I) interaction
    作者:Arpita Biswas、Suraj Mondal、Leena Mandal、Arpita Jana、Priyanka Chakraborty、Sasankasekhar Mohanta
    DOI:10.1016/j.ica.2014.01.045
    日期:2014.4
    The work in this report describes the syntheses and crystal structures of nine copper(II)-silver(I) compounds derived from some single-compartment N(imine)(2)O(phenoxo)(2) or double-compartment N(imine)(2)O(phenoxo)(2)-O(phenoxo)(2)O(methoxy/ethoxy)(2) acyclic Schiff base ligands. The nine compounds are [Cu-II(ClO4)(Lsal-enAgI)}(2)Cu-II(ClO4)(Lsal-enAgI)(H2O)}](n) (1), [(CuLsal-pnAgI)-L-II(ClO4)](n) (2), [(CuLsal-pnAgI)-L-II(NO3)}(2)] (3), [((CuLacpn-en)-L-II)(2)Ag-I(MeCN)(2)](ClO4) (4), [(CuLOMe-enAgI)-L-II(NO3)}(2)] (5), [(CuLOMe-pnAgI)-L-II(NO3)}(2)] (6), [(CuLOMe-pnAgI)-L-II(NO3)}(2)]center dot 2H(2)O (7), [(CuLOEt-enAgI)-L-II(NO3)}(2)] (8) and [(CuLOEt-opAgI)-L-II(MeOH)}(2)](ClO4)(2) (9), where the superscripts in the ligand symbols mean the following: (i) sal, acpn, OMe and OEt indicate that the aldehyde counterpart is salicylaldehyde, 2-hydroxyacetophenone, 3-methoxysalicylaldehyde and 3-ethoxysalicylaldehyde, respectively; (ii) en, pn and op indicate that the diamine counterpart is ethylenediamine, 1,3-diaminopropane and o-phenylenediamine, respectively. Copper(II) in all these compounds occupies a N2O2 compartment and the two phenoxo oxygen atoms in all cases bridge one copper(II) and one silver(I) centers. Compound 4 is a trinuclear (CuAgCuII)-Ag-II-Cu-I system. Compounds 3 and 5-9 are dimer-of-dinuclear compounds, in which the dimerization takes place due to interdinuclear Cu-O(nitrate) and Ag center dot center dot center dot Ag interactions in 3, 5 and 6 and due to Ag-pi (eta(1)-/eta(2)-) bonds in 7-9. Compounds 2 and 1 are one-dimensional coordination polymers due to Ag-pi (eta(2)-)/Ag-pi (eta(3)-) bonds. CSD search/ analysis reveals some definite significant aspects in both the Ag-pi and Ag-pi (eta(3)-) bonds. CSD search/analysis reveals some definite significant aspects in both the Ag-pi and Ag center dot center dot center dot Ag bonded systems in the present investigation. (C) 2014 Elsevier B. V. All rights reserved.
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯